First-in-man trial demonstrates safety, promising functional response rates
TMAO pathway impacts infarct size and functional impairment in preclinical stroke models
Interhemispheric inhibition study signals potential for tailored therapy
Working with a dedicated cadre of stroke specialists helps curb cerebrovascular accidents
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Hospital transfer compromises outcomes, and Target: Stroke proves its value
Learnings on cost-effectiveness, working with municipalities and more
Group advocates for stroke systems of care supported by telestroke and proper reimbursement
Insights on the PROTECTED TAVR and WATCH-TAVR trials
New expert guidance underscores need for response scalability
$2M NIH grant will help see if dual-action agent lengthens treatment window
Advertisement
Advertisement